Genetic variants of the sulfotransferase 1A1 and breast cancer risk

Breast Cancer Research and Treatment

Volumn 87, Issue 1, 2004, Pages 19-22

  Langsenlehner, Uwe ^a   Krippl, Peter ^b   Renner, Wilfried ^c   Yazdani Biuki, Babak ^d   Eder, Tanja ^b   Wolf, Gerald ^e   Wascher, Thomas C ^f   Paulweber, Bernhard ^g   Weitzer, Werner ^b   Samonigg, Hellmut ^b  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b VA Puget Sound Hlth Care Syst S   (United States)

^c Clin Inst Med Lab Diagnostics   (Austria)

^d Division of Rheumatology   (United States)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

^f Department of Internal Medicine ^*

^g Salzburger Landeskliniken   (Austria)

Author keywords

breast cancer; epidemiology; genetics; sulfotransferase 1A1; SULT1A1 638G > A polymorphism

Indexed keywords

ARYL SULFOTRANSFERASE; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ARYLSULFOTRANSFERASE; BREAST NEOPLASMS; CARCINOGENS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 4544276744     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000041574.90735.ea     Document Type: Article

References (13)

1. El-Bayoumy K: Environmental carcinogens that may be involved in human breast cancer etiology. Chem Res Toxicol 5: 570-585, 1992
2. Williams JA, Stone EM, Fakis G, Johnson N, Cordell JA, Meinl W, Glatt H, Sim E, Phillips DH: N -Acetyltransferases, sulfotransferases and heterocyclic amine activation in the breast. Pharmacogenetics 11: 373-388, 2001
3. Glatt H: Bioactivation of mutagens via sulfation. FASEB J 11: 314-321, 1997
4. Nagata K, Yamazoe Y: Pharmacogenetics of sulfotransferase. Annu Rev Pharmacol Toxicol 40: 159-176, 2000
5. Dooley TP: Cloning of the human phenol sulfotransferase gene family: three genes implicated in the metabolism of catecholamines, thyroid hormones and drugs. Chem Biol Interact 109: 29-41, 1998
6. Raftogianis RB, Wood TC, Weinshilboum RM: Human phenol sulfotransferases SULT1A2 and SULT1A1: genetic polymorphisms, allozyme properties, and human liver genotype phenotype correlations. Biochem Pharmacol 58: 605-616, 1999
7. Glatt H, Meinl W: Pharmacogenetics of soluble sulfotransferases (SULTs). Naunyn Schmiedebergs Arch Pharmacol 369: 55-68, 2004
8. Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W, Folsom AR: Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10: 89-94, 2001
9. Tang D, Rundle A, Mooney L, Cho S, Schnabel F, Estabrook A, Kelly A, Levine R, Hibshoosh H, Perera F: Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study. Breast Cancer Res Treat 78: 217-222, 2003
10. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher T. C, Paulweber B, Haas J, Samonigg H: A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 106: 468-471, 2003
11. Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Wolf G, Wascher T. C, Paulweber B, Weitzer W, Samonigg H: The common 677C > T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk. Breast Cancer Res Treat 81: 169-172, 2003
12. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B., Wolf G, Wascher T. C, Paulweber B, Bahadori B, Samonigg H: The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk. Cancer Lett 201: 181-184, 2003
13. Krippl, P, Langsenlehner, U, Renner, W, Yazdani-Biuki B, Wolf G, Wascher T. C, Paulweber B, Weitzer W, Leithner A, Samonigg H: The 870G > A polymorphism of the Cyclin D1 gene is not associated with breast cancer. Breast Cancer Res Treat 82: 165-168, 2003